James E. Levin
University of Pittsburgh
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by James E. Levin.
Pediatrics | 2009
Chris Feudtner; James E. Levin; Rajendu Srivastava; Denise M. Goodman; Anthony D. Slonim; Vidya Sharma; Samir S. Shah; Susmita Pati; Crayton A. Fargason; Matthew Hall
BACKGROUND. Children with complex chronic conditions depend on both their families and systems of pediatric health care, social services, and financing. Investigations into the workings of this ecology of care would be advanced by more accurate methods of population-level predictions of the likelihood for future hospitalization. METHODS. This was a retrospective cohort study. Hospital administrative data were collected from 38 childrens hospitals in the United States for the years 2003–2005. Participants included patients between 2 and 18 years of age discharged from an index hospitalization during 2004. Patient characteristics documented during the index hospitalization or any previous hospitalization during the preceding 365 days were included. The main outcome measure was readmission to the hospital during the 365 days after discharge from the index admission. RESULTS. Among the cohort composed of 186856 patients discharged from the participating hospitals during 2004, the mean age was 9.2 years, with 54.4% male and 52.9% identified as non-Hispanic white. A total of 17.4% were admitted during the previous 365 days, and among those discharged alive (0.6% died during the admission), 16.7% were readmitted during the ensuing 365 days. The final readmission model exhibited a c statistic of 0.81 across all hospitals, with a range from 0.76 to 0.84 for each hospital. Bootstrap-based assessments demonstrated the stability of the final model. CONCLUSIONS. Accurate population-level prediction of hospital readmissions is possible, and the resulting predicted probability of hospital readmission may prove useful for health services research and planning.
Clinical Infectious Diseases | 2009
Samir S. Shah; Matthew Hall; Raj Srivastava; Anupama Subramony; James E. Levin
BACKGROUND Streptococcal toxic shock syndrome (TSS) is a rare and severe manifestation of group A streptococcal infection. The role of intravenous immunoglobulin (IVIG) for streptococcal TSS in children is controversial. This study aims to describe the epidemiology of streptococcal TSS in children and to determine whether adjunctive therapy with IVIG is associated with improved outcomes. METHODS A multicenter, retrospective cohort study of children with streptococcal TSS from 1 January 2003 through 31 December 2007 was conducted. Propensity scores were used to determine each childs likelihood of receiving IVIG. Differences in the primary outcomes of death, hospital length of stay, and total hospital costs were compared after matching IVIG recipients and nonrecipients on propensity score. RESULTS The median patient age was 8.2 years. IVIG was administered to 84 (44%) of 192 patients. The overall mortality rate was 4.2% (95% confidence interval, 1.8%-8.0%). Differences in mortality between IVIG recipients (n = 3; 4.5%) and nonrecipients (n = 3; 4.5%) were not statistically significant (p > .99). Although patients receiving IVIG had higher total hospital and drug costs than nonrecipients, differences in hospital costs were not significant once drug costs were removed (median difference between matched patients,
Journal of Hospital Medicine | 2011
Samir S. Shah; Matthew Hall; Jason G. Newland; Thomas V. Brogan; Reid Farris; Derek J. Williams; Gitte Y. Larsen; Bryan R. Fine; James E. Levin; Jeffrey S. Wagener; Patrick H. Conway; Angela L. Myers
6139; interquartile range, -
Pediatrics | 2016
Phuong Tan Nguyen-Ha; Denise L. Howrie; Kelli Crowley; Carol G. Vetterly; William McGhee; Donald Berry; Elizabeth Ferguson; Emily Polischuk; Maria Mori Brooks; Jeffrey Goff; Terri Stillwell; Toni Darville; Ann Thompson; James E. Levin; Marian G. Michaels; Michael Green
8316 to
hawaii international conference on system sciences | 2013
Yiye Zhang; James E. Levin; Rema Padman
25,993; P = .06). No differences were found in length of hospital stay between matched IVIG recipients and nonrecipients. CONCLUSION This multicenter study is, to our knowledge, the largest to describe the epidemiology and outcomes of children with streptococcal TSS and the first to explore the association between IVIG use and clinical outcomes. IVIG use was associated with increased costs of caring for children with streptococcal TSS but was not associated with improved outcomes.
JAMA Pediatrics | 2007
Samir S. Shah; Matthew Hall; Denise M. Goodman; Pamela Feuer; Vidya Sharma; Crayton A. Fargason; Daniel Hyman; Kathy J. Jenkins; Marjorie Lee White; Fiona H. Levy; James E. Levin; David Bertoch; Anthony D. Slonim
OBJECTIVE To determine the comparative effectiveness of common pleural drainage procedures for treatment of pneumonia complicated by parapneumonic effusion (ie, complicated pneumonia). DESIGN Multicenter retrospective cohort study. SETTING Forty childrens hospitals contributing data to the Pediatric Health Information System. PARTICIPANTS Children with complicated pneumonia requiring pleural drainage. MAIN EXPOSURES Initial drainage procedures were categorized as chest tube without fibrinolysis, chest tube with fibrinolysis, video-assisted thoracoscopic surgery (VATS), and thoracotomy. MAIN OUTCOME MEASURES Length of stay (LOS), additional drainage procedures, readmission within 14 days of discharge, and hospital costs. RESULTS Initial procedures among 3500 patients included chest tube without fibrinolysis (n = 1762), chest tube with fibrinolysis (n = 623), VATS (n = 408), and thoracotomy (n = 797). Median age was 4.1 years. Overall, 716 (20.5%) patients received an additional drainage procedure (range, 6.8-44.8% across individual hospitals). The median LOS was 10 days (range, 7-14 days across individual hospitals). The median readmission rate was 3.8% (range, 0.8%-33.3%). In multivariable analysis, differences in LOS by initial procedure type were not significant. Patients undergoing initial chest tube placement with or without fibrinolysis were more likely to require additional drainage procedures. However, initial chest tube without fibrinolysis was the least costly strategy. CONCLUSION There is variability in the treatment and outcomes of children with complicated pneumonia. Outcomes were similar in patients undergoing initial chest tube placement with or without fibrinolysis. Those undergoing VATS received fewer additional drainage procedures but had no differences in LOS compared with other strategies.
Academic Emergency Medicine | 2011
Marion R. Sills; Matthew Hall; Harold K. Simon; Evan S. Fieldston; Nicholas D. Walter; James E. Levin; Thomas V. Brogan; Paul D. Hain; Denise M. Goodman; D. D. Fritch-Levens; Daniel B. Fagbuyi; Michael B. Mundorff; Anne M. Libby; Heather O. Anderson; William V. Padula; Samir S. Shah
BACKGROUND: Infectious Diseases Society of America guidelines recommend that key antimicrobial stewardship program (ASP) personnel include an infectious disease (ID) physician leader and dedicated ID-trained clinical pharmacist. Limited resources prompted development of an alternative model by using ID physicians and service-based clinical pharmacists at a pediatric hospital. The aim of this study was to analyze the effectiveness and impact of this alternative ASP model. METHODS: The collaborative ASP model incorporated key strategies of education, antimicrobial restriction, day 3 audits, and practice guidelines. High-use and/or high-cost antimicrobial agents were chosen with audits targeting vancomycin, caspofungin, and meropenem. The electronic medical record was used to identify patients requiring day 3 audits and to communicate ASP recommendations. Segmented regression analyses were used to analyze quarterly antimicrobial agent prescription data for the institution and selected services over time. RESULTS: Initiation of ASP and day 3 auditing was associated with blunting of a preexisting increasing trend for caspofungin drug starts and use and a significant downward trend for vancomycin drug starts (relative change –12%) and use (–25%), with the largest reduction in critical care areas. Although meropenem use was already low due to preexisting requirements for preauthorization, a decline in drug use (–31%, P = .021) and a nonsignificant decline in drug starts (–21%, P = .067) were noted. A 3-month review of acceptance of ASP recommendations found rates of 90%, 93%, and 100% for vancomycin, caspofungin, and meropenem, respectively. CONCLUSIONS: This nontraditional ASP model significantly reduced targeted drug usage demonstrating acceptance of integration of service-based clinical pharmacists and ID consultants.
Studies in health technology and informatics | 2013
Yiye Zhang; Rema Padman; James E. Levin
Order sets as part of computerized provider order entry (CPOE) have the potential to improve care delivery by making it faster and easier for physicians to enter orders and by guiding care according to known best practices. Currently, order sets are not utilized to their full extent due to factors such as user inexperience, lack of updated content with evolving best practices, and inability to modify an order set to include relevant items. This exploratory study uses order data from Asthma and Appendectomy patients at a large pediatric healthcare institution to examine the optimization of current ordering patterns using direct and cognitive click-through costs as evaluation criteria. We examine four models where modifications to current ordering practices are analyzed: improving order set usage through removal of inexperienced-user effect, changed default setting based on scientific evidence, and newly designed order sets through K-means clustering. While improving current ordering practice was found to reduce cost across all diagnoses and severity levels, the most significant decrease in cost was realized when clustering individual items into new order sets, pointing to a promising new approach for order set optimization.
american medical informatics association annual symposium | 2012
Yiye Zhang; James E. Levin; Rema Padman
american medical informatics association annual symposium | 2012
Hannah I. Levin; James E. Levin; Steven G. Docimo